Im Cannabis Corp. (IMCC) intrinsic value & 10-year financials
Im Cannabis Corp. (IMCC) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 7 fiscal years revenue grew 28.1% a year to CAD 54.7M, with an average return on invested capital of -42.9%.
- Graham intrinsic value
- —
- Revenue (FY2025)
- CAD 54.7M
- Revenue growth (7-yr CAGR)
- 28.1%
- ROIC (10-yr avg)
- -42.9%
- Free cash flow (FY2025)
- CAD 4.7M
IMCC 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | CAD 54.7M | -CAD 11.8M | — | CAD 4.7M | -21.2% | -86.4% |
| FY2024 | CAD 54.0M | -CAD 11.8M | -CAD 2.25 | -CAD 1.2M | -18.9% | -44.5% |
| FY2023 | CAD 48.8M | -CAD 10.2M | -CAD 0.37 | -CAD 8.7M | -26.2% | -46.2% |
| FY2022 | CAD 54.3M | -CAD 191.3M | -CAD 13.49 | -CAD 14.2M | -56.7% | -26.4% |
| FY2021 | CAD 34.1M | -CAD 18.5M | -CAD 3.35 | -CAD 39.0M | -67.6% | -11.5% |
| FY2020 | CAD 15.9M | -CAD 28.7M | -CAD 0.95 | -CAD 10.5M | -51.9% | -42.6% |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in CAD.
Executive summary
IM Cannabis Corp. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
IM Cannabis Corp. has historically struggled to out-earn its cost of capital, averaging just -43.0% ROIC.
IM Cannabis Corp. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, IM Cannabis Corp. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-66.21 per share.